Business Strategy

Drug development proceeds from the search for drug candidates to the determination of lead compounds, non-clinical testing and clinical testing.

We are a ‘drug discovery company’ that applies for and obtains patents for lead compounds and develops them up to non-clinical and early-stage clinical trials, after which we co-develop or licence them to interested domestic and overseas pharmaceutical companies for drug discovery.

Business Strategy
Business Strategy
  • ・We will collaborate with highly specialised researchers to conduct the study and development of unique drugs.
  • ・Our aim is to develop first-in-class drugs by confirming their pharmacological effects in animal models.
  • ・We will licence our products to pharmaceutical companies both domestically and internationally.
Business Strategy
Business Strategy

Collaborative research

Aetas Pharma is currently collaborating with domestic and international research institutions on the development of M201-A and other new drugs.